![John Shiver](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John Shiver
Corporate Officer/Principal bij IGM BIOSCIENCES, INC.
Profiel
John W.
Shiver is currently the Director at International AIDS Vaccine Initiative, Inc. He is also a Special Advisor at Impresa Management LLC and the Chief Strategy Officer-Infectious Diseases Unit at IGM Biosciences, Inc. Previously, he served as the President & Director at Sanofi Pasteur VaxDesign Corp.
He was also an Independent Director at Icosavax, Inc. from 2022 to 2024.
Additionally, he held the position of Vice President-Vaccine & Biologics Basic Research at Merck & Co., Inc. Dr. Shiver obtained his doctorate degree from the University of Florida in 1985 and his undergraduate degree from Wofford College in 1978.
Actieve functies van John Shiver
Bedrijven | Functie | Begin |
---|---|---|
IGM BIOSCIENCES, INC. | Corporate Officer/Principal | 01-08-2021 |
International AIDS Vaccine Initiative, Inc.
![]() International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Directeur/Bestuurslid | 01-09-2018 |
Impresa Management LLC
![]() Impresa Management LLC Investment ManagersFinance Impresa Management LLC(Impresa Management) is a Private Equity/Venture Capital firm, a subsidiary of Devonshire Investors LLC founded in 1946.The firm is headquartered in Boston. | Consultant / Adviseur | - |
Eerdere bekende functies van John Shiver
Bedrijven | Functie | Einde |
---|---|---|
ICOSAVAX, INC. | Directeur/Bestuurslid | 19-02-2024 |
MERCK & CO., INC. | Corporate Officer/Principal | - |
Sanofi Pasteur VaxDesign Corp.
![]() Sanofi Pasteur VaxDesign Corp. Miscellaneous Commercial ServicesCommercial Services Sanofi Pasteur VaxDesign Corp. designs, develops, and manufactures in vitro models of the human immune system. The firm engages in preventing infectious disease by forecasting vaccine responses before clinical trials by providing predictive in vitro immunological models and assays. The company was founded by William Warren in 2004 and is headquartered in Orlando, FL. | President | - |
Opleiding van John Shiver
University of Florida | Doctorate Degree |
Wofford College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
IGM BIOSCIENCES, INC. | Health Technology |
MERCK & CO., INC. | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Sanofi Pasteur VaxDesign Corp.
![]() Sanofi Pasteur VaxDesign Corp. Miscellaneous Commercial ServicesCommercial Services Sanofi Pasteur VaxDesign Corp. designs, develops, and manufactures in vitro models of the human immune system. The firm engages in preventing infectious disease by forecasting vaccine responses before clinical trials by providing predictive in vitro immunological models and assays. The company was founded by William Warren in 2004 and is headquartered in Orlando, FL. | Commercial Services |
International AIDS Vaccine Initiative, Inc.
![]() International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Health Technology |
Icosavax, Inc.
![]() Icosavax, Inc. Pharmaceuticals: MajorHealth Technology Icosavax, Inc. engages in the development and commercialization of vaccines against infectious diseases. It focuses on developing vaccine candidates for viral causes of pneumonia in older adults. The company was founded by Neil King and David Baker on November 1, 2017 and is headquartered in Seattle, WA. | Health Technology |
Impresa Management LLC
![]() Impresa Management LLC Investment ManagersFinance Impresa Management LLC(Impresa Management) is a Private Equity/Venture Capital firm, a subsidiary of Devonshire Investors LLC founded in 1946.The firm is headquartered in Boston. | Finance |